[go: up one dir, main page]

FR2952649B1 - Applications therapeutiques et diagnostiques contre les trypanosomoses animales africaines - Google Patents

Applications therapeutiques et diagnostiques contre les trypanosomoses animales africaines

Info

Publication number
FR2952649B1
FR2952649B1 FR0958035A FR0958035A FR2952649B1 FR 2952649 B1 FR2952649 B1 FR 2952649B1 FR 0958035 A FR0958035 A FR 0958035A FR 0958035 A FR0958035 A FR 0958035A FR 2952649 B1 FR2952649 B1 FR 2952649B1
Authority
FR
France
Prior art keywords
trypanosomoses
therapeutic
diagnostic applications
applications against
against african
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0958035A
Other languages
English (en)
Other versions
FR2952649A1 (fr
Inventor
Linares Virginie Coustou
Theo Baltz
Magali Thonnus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Victor Segalen Bordeaux 2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0958035A priority Critical patent/FR2952649B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Victor Segalen Bordeaux 2 filed Critical Centre National de la Recherche Scientifique CNRS
Priority to US13/509,389 priority patent/US20130108660A1/en
Priority to AU2010317967A priority patent/AU2010317967A1/en
Priority to AP2012006302A priority patent/AP2012006302A0/xx
Priority to MX2012005409A priority patent/MX2012005409A/es
Priority to BR112012011062A priority patent/BR112012011062A2/pt
Priority to CA2780208A priority patent/CA2780208A1/fr
Priority to PCT/EP2010/067208 priority patent/WO2011058055A1/fr
Priority to CN2010800514325A priority patent/CN102762588A/zh
Priority to EP10779306A priority patent/EP2499157A1/fr
Publication of FR2952649A1 publication Critical patent/FR2952649A1/fr
Application granted granted Critical
Publication of FR2952649B1 publication Critical patent/FR2952649B1/fr
Priority to ZA2012/03286A priority patent/ZA201203286B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/005—Trypanosoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
FR0958035A 2009-11-13 2009-11-13 Applications therapeutiques et diagnostiques contre les trypanosomoses animales africaines Expired - Fee Related FR2952649B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0958035A FR2952649B1 (fr) 2009-11-13 2009-11-13 Applications therapeutiques et diagnostiques contre les trypanosomoses animales africaines
CN2010800514325A CN102762588A (zh) 2009-11-13 2010-11-10 抗锥虫病的治疗和诊断应用
AP2012006302A AP2012006302A0 (en) 2009-11-13 2010-11-10 Anti-trypanosome therapeutic and diagnostic applications.
MX2012005409A MX2012005409A (es) 2009-11-13 2010-11-10 Aplicaciones terapeuticas y de diagnostico contra tripanosomosis.
BR112012011062A BR112012011062A2 (pt) 2009-11-13 2010-11-10 aplicações terapêuticas e de diagnóstico contra tripanossomose.
CA2780208A CA2780208A1 (fr) 2009-11-13 2010-11-10 Applications therapeutiques et diagnostics contre les trypanosomoses
US13/509,389 US20130108660A1 (en) 2009-11-13 2010-11-10 Anti-trypanosome therapeutic and diagnostic applications
AU2010317967A AU2010317967A1 (en) 2009-11-13 2010-11-10 Anti-trypanosome therapeutic and diagnostic applications
EP10779306A EP2499157A1 (fr) 2009-11-13 2010-11-10 Applications therapeutiques et diagnostics contre les trypanosomoses
PCT/EP2010/067208 WO2011058055A1 (fr) 2009-11-13 2010-11-10 Applications therapeutiques et diagnostics contre les trypanosomoses
ZA2012/03286A ZA201203286B (en) 2009-11-13 2012-05-07 Therapeutic and diagnostic applications against trypanosomosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0958035A FR2952649B1 (fr) 2009-11-13 2009-11-13 Applications therapeutiques et diagnostiques contre les trypanosomoses animales africaines

Publications (2)

Publication Number Publication Date
FR2952649A1 FR2952649A1 (fr) 2011-05-20
FR2952649B1 true FR2952649B1 (fr) 2012-05-04

Family

ID=42310605

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0958035A Expired - Fee Related FR2952649B1 (fr) 2009-11-13 2009-11-13 Applications therapeutiques et diagnostiques contre les trypanosomoses animales africaines

Country Status (11)

Country Link
US (1) US20130108660A1 (fr)
EP (1) EP2499157A1 (fr)
CN (1) CN102762588A (fr)
AP (1) AP2012006302A0 (fr)
AU (1) AU2010317967A1 (fr)
BR (1) BR112012011062A2 (fr)
CA (1) CA2780208A1 (fr)
FR (1) FR2952649B1 (fr)
MX (1) MX2012005409A (fr)
WO (1) WO2011058055A1 (fr)
ZA (1) ZA201203286B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015025951A2 (pt) * 2013-04-12 2017-10-17 Univ Danmarks Tekniske sialidase mutante com atividade trans-sialidase, para uso em produção de glicanos sialilados
CN103278642A (zh) * 2013-05-15 2013-09-04 广西大学 一种检测伊氏锥虫vsg抗原的双抗体夹心酶联免疫吸附测定试剂盒及制备方法
EP3215849B1 (fr) * 2014-11-06 2018-12-19 Roche Diagnostics GmbH Variants d'antigène jl7 recombinants de trypanosoma cruzi et leur utilisation pour la détection de la maladie de chagas
US20240156935A1 (en) * 2021-03-31 2024-05-16 Vib Vzw Vaccine Compositions for Trypanosomatids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR958035A (fr) 1950-03-02
WO1992022325A1 (fr) * 1991-06-13 1992-12-23 Curtis Powell Vaccin et methode de traitement des protozoaires flagelles parasites du sang
EP1048728A1 (fr) * 1999-04-26 2000-11-02 Stichting Dienst Landbouwkundig Onderzoek Moyens et méthode pour la prévention et/ou le traitement des infections par le Trypanosome
WO2002019960A2 (fr) * 2000-09-06 2002-03-14 Pays, Etienne Purification, caracterisation et utilisation de structures antigeniques protectrices contre des trypanosomes et des parasites apparentes
DE10258400A1 (de) 2002-12-13 2004-06-24 N.V. Nutricia Trans-Sialidasen aus Trypanosoma congolense
WO2007107488A2 (fr) 2006-03-17 2007-09-27 Vib Vzw Nouveau vaccin contre l'infection a trypanosoma cruzi
US8778348B2 (en) 2007-04-28 2014-07-15 Ibio Inc. Trypanosoma antigens, vaccine compositions, and related methods

Also Published As

Publication number Publication date
MX2012005409A (es) 2013-03-07
US20130108660A1 (en) 2013-05-02
AU2010317967A1 (en) 2012-06-21
CA2780208A1 (fr) 2011-05-19
AP2012006302A0 (en) 2012-06-30
EP2499157A1 (fr) 2012-09-19
WO2011058055A1 (fr) 2011-05-19
BR112012011062A2 (pt) 2019-09-24
FR2952649A1 (fr) 2011-05-20
CN102762588A (zh) 2012-10-31
ZA201203286B (en) 2013-07-31

Similar Documents

Publication Publication Date Title
BR112012001637A2 (pt) dispositivo médico implantável
EP2429609A4 (fr) Stérilisation d'introduction de cathéter
EP2430991A4 (fr) Manipulateur médical
DK3028564T5 (da) Dyremodeller og terapeutiske molekyler
BRPI1011587A2 (pt) compostos e composições terapèuticas
DK3590949T3 (da) Ribonukleinsyrer indeholdende n1-methyl-pseudouracil og anvendelse heraf
FI20105569L (fi) Kehonsisäinen hoitolaite
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
DK2094029T3 (da) Implanterbar transducer
EP2442709C0 (fr) Sphygmo-oxymètre porté sur le corps
DK2415771T3 (da) Indolizinderivat og anvendelse deraf til medicinske formål
BR112012007861A2 (pt) dispositivos médicos e suas bombas
BR112012000032A2 (pt) meios terapêuticos e diagnósticos inovadores
BR112012003844A2 (pt) vacinas de pttv e diagnóstico
DK2274619T3 (da) Slimhindereceptor og anvendelser deraf
EP2433996A4 (fr) Composition adhésive et endoscope
IT1398295B1 (it) Collegamento flessibile per albero e procedimento
EP2629599A4 (fr) Lutte contre les pathogènes et les parasites
DK2252688T3 (da) Syntetiske phosphodiester-oligonukleotider og terapeutiske anvendelser deraf
BRPI1007909A2 (pt) método e dispositivo médico
EP2733960A4 (fr) Élément ultrasonique, et endoscope ultrasonique
EP2438167A4 (fr) Molécules thérapeutiques et diagnostiques
EP2440055A4 (fr) Dérivés de la styryl-triazine et leurs applications thérapeutiques
EP2384199A4 (fr) Implant médical perfectionné
EP2614824A4 (fr) Agent thérapeutique contre la douleur

Legal Events

Date Code Title Description
CD Change of name or company name

Owner name: UNIVERSITE BORDEAUX SEGALEN, FR

Effective date: 20110822

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -, FR

Effective date: 20110822

ST Notification of lapse

Effective date: 20140731